Researchers from King’s have found that therapy that can induce heart cells...
Researchers from King’s have found that therapy that can induce heart cells to regenerate after a heart attack.

Myocardial infarction

Genetic therapy heals damage caused by heart attack

Researchers from King's College London have found that therapy that can induce heart cells to regenerate after a heart attack.

Myocardial infarction, more commonly known as a heart attack, caused by the sudden blocking of one of the cardiac coronary arteries, is the main cause of heart failure, a condition that now affects over 23 million population in the world, according to the World Health Organisation.
At present, when a patient survives a heart attack, they are left with permanent structural damage to their heart through the formation of a scar, which can lead to heart failure in the future. In contrast to fish and salamander, which can regenerate the heart throughout life.

In the study, the team of investigators delivered a small piece of genetic material, called microRNA-199, to the heart of pigs, after a myocardial infarction which resulted in the almost complete recovery of cardiac function at one month later. Lead author Professor Mauro Giacca from King’s said: “It is a very exciting moment for the field. After so many unsuccessful attempts at regenerating the heart using stem cells, which all have failed so far, for the first time we see real cardiac repair in a large animal.”

This is the first demonstration that cardiac regeneration can be achieved by administering an effective genetic drug that stimulates cardiac regeneration in a large animal, with heart anatomy and physiology like that of humans. “It will take some time before we can proceed to clinical trials,” said Professor Giacca. “We still need to learn how to administer the RNA as a synthetic molecule in large animals and then in patients, but we already know this works well in mice."

Professor Ajay Shah, British Heart Foundation (BHF) Chair of Cardiology and Head of the School of Cardiovascular Medicine and Sciences at King's said: "A treatment that helps the heart repair itself after a heart attack is the holy grail for cardiologists. Professor Giacca’s study convincingly demonstrates for the first time that this might actually be feasible and not just a pipe-dream. It’s a very exciting advance in the field. While we are not yet at a stage where a treatment could be offered to patients, I’m confident that our excellent team in the King’s BHF Centre of Excellence is very well placed to drive forward the research to make such a treatment a reality.”

Source: King's College London

13.05.2019

Read all latest stories

Related articles

Photo

Simplified catheter ablation

“Back to basics” atrial fibrillation procedure could cut waiting lists

A day case catheter ablation procedure which includes only the bare essentials and delivers the same outcomes could slash waiting lists for atrial fibrillation patients, according to late-breaking…

Photo

Matrix-forming proteins

Experimental targeted therapy might prevent heart failure

Scientists used an experimental targeted molecular therapy to block a matrix-forming protein in heart cells damaged by heart attack, reducing levels of scarred muscle tissue and saving mouse models…

Photo

Power of the heart

Gene therapy can make the heart stop atrial fibrillation itself

The heart is capable of terminating arrhythmias itself after local gene therapy, potentially avoiding the need for patients to undergo painful electric shocks, according to a proof-of-concept study…

Related products

Agena Bioscience - MassARRAY Colon Panel

Amplification/Detection

Agena Bioscience - MassARRAY Colon Panel

Agena Bioscience GmbH
Eppendorf – BioSpectrometer fluroescence

Research Use Only (RUO)

Eppendorf – BioSpectrometer fluroescence

Eppendorf AG
Eppendorf – Mastercycler nexus X2

Research Use Only (RUO)

Eppendorf – Mastercycler nexus X2

Eppendorf AG
Eppendorf – μCuvette G1.0

Research Use Only (RUO)

Eppendorf – μCuvette G1.0

Eppendorf AG
Orion Diagnostica Oy – Orion GenRead

Amplification

Orion Diagnostica Oy – Orion GenRead

Orion Diagnostics Oy